The Chemours Company (CC) reported a fourth-quarter net loss of $47 million or $0.31 per share, compared with a net loss of $11 million or $0.08 per share in the corresponding prior-year quarter.
Adjusted net Income was $7 million or $0.05 per share, compared to adjusted net income of $14 million or $0.09 per share in the corresponding prior-year quarter.
Net sales were $1.33 billion, slightly down from $1.36 billion compared to the corresponding prior-year quarter.
Looking forward to the first quarter, the Company anticipates consolidated Net Sales to increase in the range of 3 to 5% sequentially, driven by TSS, with consolidated Adjusted EBITDA expected to range between $120 million and $150 million.
For the full year 2026, the company expects to deliver 2026 net sales growth in the range of 3 to 5% and adjusted EBITDA of $800 million to $900 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.